Alpha Tau Medical (DRTS) News Today $2.48 -0.10 (-3.72%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent GlioblastomaApril 2 at 8:30 AM | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 60.7% in MarchAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 122,000 shares, an increase of 60.7% from the February 28th total of 75,900 shares. Approximately 0.2% of the company's shares are sold short. Based on an average trading volume of 89,000 shares, the short-interest ratio is presently 1.4 days.March 30, 2025 | marketbeat.comHead-To-Head Survey: Vivos Therapeutics (NASDAQ:VVOS) versus Alpha Tau Medical (NASDAQ:DRTS)March 28, 2025 | americanbankingnews.comHC Wainwright Expects Reduced Earnings for Alpha Tau MedicalAlpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - HC Wainwright decreased their FY2025 EPS estimates for shares of Alpha Tau Medical in a report issued on Monday, March 17th. HC Wainwright analyst Y. Chen now expects that the company will post earnings of ($0.53) per share for the year, down fMarch 20, 2025 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Given Buy Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $9.00 target price on shares of Alpha Tau Medical in a research note on Monday.March 18, 2025 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Announces Earnings ResultsAlpha Tau Medical (NASDAQ:DRTS - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.13) EPS for the quarter, meeting the consensus estimate of ($0.13).March 13, 2025 | marketbeat.comAlpha Tau Announces Full Year 2024 Financial Results and Provides Corporate UpdateMarch 12, 2025 | globenewswire.comAlpha Tau to Participate in March Investor ConferencesFebruary 27, 2025 | markets.businessinsider.comAlpha Tau Receives Medical Device Single Audit Program (MDSAP) CertificationFebruary 24, 2025 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest UpdateAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 101,900 shares, a decline of 21.6% from the January 15th total of 130,000 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 85,200 shares, the short-interest ratio is currently 1.2 days.February 16, 2025 | marketbeat.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Increase in Short InterestAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a large increase in short interest in January. As of January 15th, there was short interest totalling 72,600 shares, an increase of 7.1% from the December 31st total of 67,800 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average trading volume of 45,600 shares, the short-interest ratio is presently 1.6 days.February 4, 2025 | marketbeat.comAlpha Tau announces FDA approval of IDE supplementFebruary 3, 2025 | msn.comAlpha Tau DaRT Shows Promising Interim Data In Cancer Trials, Shares RiseJanuary 29, 2025 | nasdaq.comAlpha Tau announces interim data from pembrolizumab combination trialJanuary 28, 2025 | markets.businessinsider.comAlpha Tau receives IDE from FDA for study evaluating Alpha DaRT, chemo comboJanuary 27, 2025 | markets.businessinsider.comAlpha Tau shares interim data across multiple clinical trials at R&D Update DayJanuary 27, 2025 | markets.businessinsider.comDRTS Stock Soars to 52-Week High, Reaching $4.12 Amid Healthcare SurgeJanuary 27, 2025 | msn.comAlpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update DayJanuary 27, 2025 | globenewswire.comShort Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 7.1%Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) saw a significant increase in short interest in December. As of December 31st, there was short interest totalling 72,600 shares, an increase of 7.1% from the December 15th total of 67,800 shares. Currently, 0.1% of the company's shares are short sold. Based on an average trading volume of 45,600 shares, the days-to-cover ratio is currently 1.6 days.January 19, 2025 | marketbeat.comAlpha Tau to Present Groundbreaking Cancer Therapy Data at ASCO SymposiumDecember 19, 2024 | markets.businessinsider.comAlpha Tau Medical Ltd. Announces Key Shareholder Decisions at Annual MeetingDecember 18, 2024 | markets.businessinsider.comAlpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update DayDecember 18, 2024 | globenewswire.comAlpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as AdvisorDecember 17, 2024 | globenewswire.comAlpha Tau Medical (NASDAQ:DRTS) Stock Price Up 1% - Should You Buy?Alpha Tau Medical (NASDAQ:DRTS) Shares Up 1% - Still a Buy?December 17, 2024 | marketbeat.comAlpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 11, 2024 | globenewswire.comAlpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors SymposiumDecember 6, 2024 | markets.businessinsider.comAlpha Tau to Participate in Ladenburg's Oncology Innovators & Investors SymposiumDecember 6, 2024 | globenewswire.comAlpha Tau Medical (NASDAQ:DRTS) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $9.00 price objective on shares of Alpha Tau Medical in a research report on Friday.November 22, 2024 | marketbeat.comAlpha Tau transferred with Buy rating at CitiNovember 15, 2024 | markets.businessinsider.comAlpha Tau Medical Ltd: A Unique Player in Radiopharmaceuticals with Promising Advances in Alpha DaRT TechnologyNovember 15, 2024 | markets.businessinsider.comShort Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Grows By 30.5%Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 67,100 shares, a growth of 30.5% from the October 15th total of 51,400 shares. Based on an average daily volume of 22,200 shares, the days-to-cover ratio is currently 3.0 days. Approximately 0.1% of the company's stock are short sold.November 15, 2024 | marketbeat.comAlpha Tau to Participate in Citi's 2024 Global Healthcare Conference and Piper Sandler's 36th Annual Healthcare ConferenceNovember 13, 2024 | globenewswire.comAlpha Tau Medical (NASDAQ:DRTS) Receives "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $9.00 price objective on shares of Alpha Tau Medical in a report on Wednesday.October 23, 2024 | marketbeat.comAlpha Tau announces acceptance into FDA’s TPLC TAP PilotOctober 22, 2024 | markets.businessinsider.comAlpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma MultiformeOctober 21, 2024 | globenewswire.comAlpha Tau Medical's (DRTS) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $9.00 price objective on shares of Alpha Tau Medical in a research report on Friday.October 11, 2024 | marketbeat.comAlpha Tau Treats First Patient with Recurrent Lung CancerOctober 10, 2024 | globenewswire.comFDA approves study of Alpha Tau’s Alpha DaRT for recurrent cSCC treatmentSeptember 23, 2024 | msn.comAlpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCCSeptember 20, 2024 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 63.4% in AugustAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 33,000 shares, an increase of 63.4% from the August 15th total of 20,200 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 33,200 shares, the short-interest ratio is presently 1.0 days.September 13, 2024 | marketbeat.comAlpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor ConferenceAugust 22, 2024 | globenewswire.comAlpha Tau Medical Ltd. to Post FY2024 Earnings of ($0.47) Per Share, HC Wainwright Forecasts (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Research analysts at HC Wainwright reduced their FY2024 EPS estimates for shares of Alpha Tau Medical in a report issued on Tuesday, August 20th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.47) per share for the yAugust 22, 2024 | marketbeat.comAlpha Tau Medical's (DRTS) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $9.00 target price on shares of Alpha Tau Medical in a research report on Tuesday.August 20, 2024 | marketbeat.comAlpha Tau Medical Ltd.: Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 16, 2024 | finanznachrichten.dePiper Sandler Reaffirms Their Buy Rating on Alpha Tau Medical Ltd (DRTS)August 16, 2024 | markets.businessinsider.comAlpha Tau Medical (NASDAQ:DRTS) Stock Rating Reaffirmed by Piper SandlerPiper Sandler reiterated an "overweight" rating and set a $7.00 price target on shares of Alpha Tau Medical in a research report on Thursday.August 15, 2024 | marketbeat.comAlpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 14, 2024 | globenewswire.comShort Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Grows By 60.8%Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totalling 28,300 shares, a growth of 60.8% from the June 15th total of 17,600 shares. Based on an average daily volume of 41,300 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.1% of the shares of the stock are sold short.July 12, 2024 | marketbeat.comAlpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial CancersJune 25, 2024 | globenewswire.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Drop in Short InterestAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) saw a large decline in short interest in May. As of May 15th, there was short interest totalling 26,900 shares, a decline of 6.9% from the April 30th total of 28,900 shares. Approximately 0.1% of the company's stock are sold short. Based on an average trading volume of 34,800 shares, the short-interest ratio is currently 0.8 days.June 4, 2024 | marketbeat.com Remove Ads Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address DRTS Media Mentions By Week DRTS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRTS News Sentiment▼0.650.60▲Average Medical News Sentiment DRTS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRTS Articles This Week▼31▲DRTS Articles Average Week Remove Ads Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CBLL News EMBC News BFLY News IRMD News AVNS News BBNX News SIBN News KIDS News OM News TMCI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRTS) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DRTS Stock Free DRTS Stock Alerts